z-logo
Premium
Chiral Platinum(II) Compounds Containing Ferrocenyl Schiff Bases Acting as (N), (N,O) – , [C(sp 2 ,ferrocene),N] – or [C(sp 2 ,ferrocene),N,O] 2– Ligands
Author(s) -
López Concepción,
Caubet Amparo,
Pérez Sonia,
Solans Xavier,
FontBardía Mercè,
Molins Elies
Publication year - 2006
Publication title -
european journal of inorganic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.667
H-Index - 136
eISSN - 1099-0682
pISSN - 1434-1948
DOI - 10.1002/ejic.200600179
Subject(s) - chemistry , diastereomer , ligand (biochemistry) , ferrocene , stereochemistry , medicinal chemistry , imine , platinum , electrochemistry , catalysis , organic chemistry , biochemistry , receptor , electrode
A study of the reactions of the following ferrocenyl Schiff bases: ( S C )‐(+)‐[FcCH=NCH(R 1 )CH 2 OH] {Fc = (η 5 ‐C 5 H 5 )Fe(η 5 ‐C 5 H 4 ), R 1 = Me ( 1a ) or CHMe 2 ( 1b )} with cis ‐[PtCl 2 (dmso) 2 ] under different experimental conditions is reported. This study enabled the isolation and characterisation of the enantiomerically pure platinum(II) complexes trans ‐( S C )‐[Pt{FcCH=NCH(R 1 )CH 2 OH}Cl 2 (dmso)] {R 1 = Me ( 2a )or CHMe 2 ( 2b )} and cis ‐( S C )‐[Pt{FcCH=NCH(R 1 )CH 2 OH}Cl 2 (dmso)] {R 1 = Me ( 3a ) or CHMe 2 ( 3b )} as well as four isomeric forms of ( S C )‐[Pt{FcCH=N–CH(R 1 )CH 2 O}Cl(dmso)] {R 1 = Me or CHMe 2 } ( 4 – 7a , b ). These isomers differ in the conformation of the imine { anti ‐( E ) (in 4 and 6 ) or syn ‐( Z ) (in 5 and 7 )} or in the relative arrangement of the nitrogen and the dmso group { trans (in 4 and 5 ) or cis (in 6 and 7 )}. Imines 1 behave as a N‐donor ligand in 2 and 3 and as a (N,O) – group in 4 – 7 . We also prepared the diastereomers {( S p , S C ) and ( R p , S C )} of the platinacycles [Pt{[(η 5 ‐C 5 H 3 )CH=NCH(R 1 )CH 2 OH]Fe(η 5 ‐C 5 H 5 )}Cl(dmso)] { 8 and 9 ; R 1 = Me ( S p , S C ) ( 8a ) and ( R p , S C ) ( 9a ) or R 1 = CHMe 2 ( S p , S C ) ( 8b ) and ( R p , S C ) ( 9b )}, [Pt{[(η 5 ‐C 5 H 3 )CH=NCH(R 1 )CH 2 O]Fe(η 5 ‐C 5 H 5 )}(dmso)] { 10 and 11 ; R 1 = Me ( S p , S C ) ( 10a ) and ( R p , S C ) ( 11a ) or R 1 = CHMe 2 ( S p , S C ) ( 10b ) and ( R p , S C ) ( 11b )} and [Pt{[(η 5 ‐C 5 H 3 )CH=NCH(R 1 )CH 2 OH]Fe(η 5 ‐C 5 H 5 )}Cl(PPh 3 )] { 12 and 13 ; R 1 = Me ( S p , S C ) ( 12a ) and ( R p , S C ) ( 13a ) or R 1 = CHMe 2 ( S p , S C ) ( 12b ) and ( R p , S C ) ( 13b )}, containing a [C(sp 2 ,ferrocene),N] – (in 8 , 9 , 12 and 13 ) or a [C(sp 2 ,ferrocene),N,O] 2– (in 10 and 11 ) group. The X‐ray crystal structures of 1b· H 2 O, 3b , 7b· CH 2 Cl 2 · 1/2H 2 O and 9a are also reported. Our study allows the elucidation of the factors affecting the preferential formation of a given platinum(II) complex. (© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2006)

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom